Lori Friedman

Lori Friedman

Chief Tech/Sci/R&D Officer at ORIC PHARMACEUTICALS, INC.
62 year
Health Technology
Consumer Services
Miscellaneous

Profile

Lori Friedman is currently Director at NextRNA Therapeutics, Inc. since 2023.
Director at Project Scientist since 2018.
Chief Scientific Officer at Oric Pharmaceuticals, Inc. since 2019.
Formerly Independent Director at Jiya Acquisition Corp.
Head-Translational Oncology at Genentech, Inc. Earned a doctorate from the University of California, Berkeley.

Lori Friedman active positions

CompaniesPositionStart
ORIC PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 30/06/2019
Director/Board Member 30/04/2018
Director/Board Member 25/09/2023

Former positions of Lori Friedman

CompaniesPositionEnd
JIYA ACQUISITION CORP. Director/Board Member -
Corporate Officer/Principal -
See the detail of Lori Friedman's experience

Training of Lori Friedman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

4

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Health Technology

Miscellaneous

Finance

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!